Medicare Enrolled

Dr. Anthony Caruso, MD

Urology Physician · Federal Way, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
34612 6TH AVE S, Federal Way, WA 98003
2539271882
In practice since 2005 (21 years)
NPI: 1013913938 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Caruso from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Caruso? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Caruso

Dr. Anthony Caruso is an urology physician in Federal Way, WA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Caruso performed 2,817 Medicare services across 2,084 unique beneficiaries.

Between the years covered by Open Payments, Dr. Caruso received a total of $6,472 from 58 pharmaceutical and/or device companies across 283 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Caruso is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 20% volume in WA $6,472 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,817
Medicare services
Top 20% in WA for urology physician
2,084
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~134 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
490 $2 $15
PSA test (prostate cancer screening) 426 $18 $50
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
425 $8 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
423 $99 $200
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
306 $139 $237
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
233 $10 $50
Urinalysis with microscopic exam
A urine test performed manually that includes examining the sample under a microscope to check for abnormalities.
144 $3 $15
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
131 $12 $150
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
63 $222 $395
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
61 $73 $135
New patient office visit, complex (60-74 min) 36 $185 $375
Simple measurement of urine flow pressure in bladder
A test that measures the pressure of urine flow within the bladder. This procedure assesses bladder function by recording pressure changes during urination.
34 $204 $400
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
29 $19 $50
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
16 $150 $365
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,472
Total received (2018-2024)
Avg $925/year across 7 years
Top 18% in WA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
283
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,619 (86.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$853 (13.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,165
2023
$867
2022
$1,232
2021
$623
2020
$396
2019
$1,145
2018
$1,044

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$146
UROGEN PHARMA, INC.
$136
Janssen Biotech, Inc.
$103
Merck Sharp & Dohme LLC
$98
Endo USA, Inc.
$82
Ferring Pharmaceuticals Inc.
$78
Myriad Genetic Laboratories, Inc.
$63
Astellas Pharma US Inc
$49
C. R. Bard, Inc. & Subsidiaries
$42
ACCORD HEALTHCARE, INC.
$38
AstraZeneca Pharmaceuticals LP
$35
Verity Pharmaceuticals Inc.
$31
IMMUNITYBIO, INC.
$30
PROGENICS PHARMACEUTICALS, INC.
$29
Dendreon Pharmaceuticals LLC
$27
Boston Scientific Corporation
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Endo Pharmaceuticals Inc.
$24
Calyxo, Inc.
$21
COLOPLAST CORP
$21
PFIZER INC.
$21
Laborie Medical Technologies Corp.
$20
Agiliti Surgical, Inc.
$18
Top 3 companies account for 33.0% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,138
Janssen Biotech, Inc.
$712
Coloplast Corp
$390
PFIZER INC.
$388
Bayer HealthCare Pharmaceuticals Inc.
$313
Dendreon Pharmaceuticals LLC
$276
Boston Scientific Corporation
$266
ABBVIE INC.
$181
BOSTON SCIENTIFIC CORPORATION
$165
UROGEN PHARMA, INC.
$159
Endo Pharmaceuticals Inc.
$155
Antares Pharma, Inc.
$149
Myriad Genetic Laboratories, Inc.
$125
MEDIVATION FIELD SOLUTIONS LLC
$111
Myovant Sciences Inc.
$106
Janssen Products, LP
$100
ACCORD HEALTHCARE, INC.
$99
Merck Sharp & Dohme LLC
$98
Ferring Pharmaceuticals Inc.
$96
Sun Pharmaceutical Industries Inc.
$94
Tolmar, Inc.
$93
Endo USA, Inc.
$82
AstraZeneca Pharmaceuticals LP
$77
Rochester Medical Corporation
$77
180 Medical, Inc.
$72
C. R. Bard, Inc. & Subsidiaries
$70
AbbVie, Inc.
$58
C. R. BARD, INC. & SUBSIDIARIES
$47
UROVANT SCIENCES INC
$46
UroGen Pharma, Inc.
$45
Wilmington Medical Supply, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$43
Laborie Medical Technologies Corp.
$42
AbbVie Inc.
$39
TherapeuticsMD, Inc.
$36
COLOPLAST CORP
$33
Verity Pharmaceuticals Inc.
$31
IMMUNITYBIO, INC.
$30
PROGENICS PHARMACEUTICALS, INC.
$29
Progenics Pharmaceuticals, Inc.
$27
Janssen Scientific Affairs, LLC
$27
SUN PHARMACEUTICAL INDUSTRIES INC.
$26
Avadel Specialty Pharmaceuticals, LLC
$25
Mallinckrodt LLC
$25
Novartis Pharmaceuticals Corporation
$23
Calyxo, Inc.
$21
PALETTE LIFE SCIENCES, INC.
$20
Amgen Inc.
$19
Smith+Nephew, Inc.
$18
Agiliti Surgical, Inc.
$18
TOLMAR Pharmaceuticals, Inc.
$18
Baxter Healthcare
$18
Cook Medical LLC
$18
Ambu Inc.
$17
Travere Therapeutics, Inc.
$11
UroMed, Inc.
$11
Amniox Medical, Inc.
$10
Retrophin, Inc.
$1
Top 3 companies account for 34.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ANKTIVA · AVEED · Advantage System · Altis · BOTOX · Balversa · Bard Urinary Drainage Bag · CAMCEVI · CURE ULTRA CATHETER · CVAC ASPIRATION SYSTEM · Cook Medical Extractors · ELIGARD · ERLEADA · Erleada · FASLODEX · GEMTESA · GENERAL ERECTILE DYSFUNCTION · GENERAL THERAPIES · GENERAL ERECTILE DYSFUNCTION · IMVEXXY · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · Lupron · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Noctiva · Non-Covered · Nubeqa · OBTRYX · OFIRMEV · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · Otrexup · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Prolia · SPEEDICATH · STRAVIX · Sonablate HIFU · SpeediCath · TISSEEL · TOVIAZ · Thiola · Titan · Trelstar · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Federal Way?
Compare urology physicians in the Federal Way area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
159
Per 100K population
7.0
County median income
$122,148
Nearest hospital
ST FRANCIS COMMUNITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Caruso is a clinical cardiology specialist, with above-average Medicare volume (top 20% in WA), with low-engagement industry engagement in the top 18% of WA peers, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Caruso experienced with automated urinalysis?
Based on Medicare claims data, Dr. Caruso performed 490 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Caruso receive payments from pharmaceutical companies?
Yes. Dr. Caruso received a total of $6,472 from 58 companies across 283 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Caruso's costs compare to other urology physicians in Federal Way?
Dr. Caruso's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Caruso) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →